Medicine prescribing in New Zealand hits new high as PHARMAC role expands
New Zealanders have gained greater access to medicines in 2013, and record numbers of New Zealanders received funded medicines in the past year.
Pharmacy Management Agency PHARMAC’s 2012/13 Annual Review, published last week, reveals that 3.4 million New Zealanders received a funded medicine in the past year, the highest number ever. Moreover the number of funded prescription items has also continued to grow, to a record 42.2 million.
PHARMAC chief executive Steffan Crausaz says this high level of medicine access has occurred while PHARMAC has continued to manage pharmaceutical funding within budget, and grown the scope of its work to incorporate vaccines and hospital medicines. Combined Pharmaceutical Budget spending rose to NZ$783.6 million ($639.7 million) for the year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze